Companies: 10,795·Total market cap: $144.5T
Pfizer Inc.

Pfizer Inc.

PFENYSEHealthcare● Active
$26.04
+$0.35(+1.34%)
Market Cap$148.4B
P/E Ratio
52W High$28.75
52W Low$23.08
Overview

Pfizer Inc. (PFE) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · PFE · as of 2026-06-08

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income$7.75B$8.05B$2.17B$31.40B$22.46B
Depreciation & Amort.$6.59B$7.01B$6.29B$5.06B$5.19B
Stock-Based Comp.$0.00B$0.88B$0.53B$0.87B$1.18B
Change in Working Capital($5.35B)($3.07B)($2.17B)($4.46B)$12.80B
Net Cash from Operations$11.71B$12.74B$8.70B$29.27B$32.58B
Investing Activities
Capital Expenditure($2.63B)($2.91B)($3.91B)($3.24B)($2.71B)
Purchases of Investments($14.65B)($10.31B)($31.18B)($38.78B)($47.61B)
Sales of Investments$22.69B$8.83B$46.42B$45.46B$28.10B
Net Cash from Investing($1.35B)$2.65B($32.28B)($15.78B)($22.55B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B($2.00B)$0.00B
Dividends Paid($9.77B)($9.51B)($9.25B)($8.98B)($8.73B)
Debt Issued / Repaid($0.07B)($7.16B)$35.95B($3.52B)($1.10B)
Net Cash from Financing($10.30B)($17.14B)$26.07B($14.83B)($9.82B)
Free Cash Flow
Free Cash Flow$9.08B$9.84B$4.79B$26.03B$29.87B
FCF Margin %(computed)14.50%15.46%8.05%25.95%36.74%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B

Explore more Pfizer Inc. data

About Pfizer Inc. (PFE) Cash Flow Statement

Pfizer Inc. generated operating cash flow of $11.71B and free cash flow of $9.08B for 2025 — a FCF margin of 14.50%. Capital expenditure was ($2.63B).

Frequently asked questions

PFE · 4 questions

Pfizer Inc. generated free cash flow of $9.08B for 2025, down 7.7% year-over-year.

PFE free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08